Patterns of dual TGFBR2/hTERT protein expression in the 164 cases of cervical cancer included: TGFBR2high/hTERThigh in 17 (10.4%) cases, TGFBR2high/hTERTlow in 68 (41.5%) cases, TGFBR2low/hTERThigh in 24 (14.6%) cases, and TGFBR2low/hTERTlow in 55 (33.5%) cases. This evidence concerns the gene TGFBR2 and cervical cancer.